www.nonagen.com Open in urlscan Pro
198.49.23.145  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Home
About
Who we are
Leadership
Products & Pipeline
Products
Pipeline
Technology
Disease States
Bladder Cancer
Breast Cancer
Prostate Cancer
Latest News
News
Publications
Contact Us
Home
About
Who we are
Leadership
Products & Pipeline
Products
Pipeline
Technology
Disease States
Bladder Cancer
Breast Cancer
Prostate Cancer
Latest News
News
Publications
Contact Us


Discovering and developing breakthrough diagnostics for human diseases










































DIAGNOSTICS TO HELP REDUCE THE BURDEN OF DISEASE

Nonagen Bioscience is working to translate research discoveries into
best-in-class diagnostics that change the way diseases are managed.

Our sights are set on providing doctors with advanced diagnostic tools for
disease detection, therapy choice, and disease monitoring.




THE PROMISE OF ONCURIA®

Oncuria is a first-of-its-kind multiplex protein immunoassay being developed to:

 * Aid in the diagnosis of bladder cancer

 * Monitor people with early-stage bladder cancer for recurrence

 * Predict whether people are likely to respond to bacillus Calmette-Guérin
   (BCG) therapy, a first-line treatment for bladder cancer

Learn about Oncuria





Back to Top

This site is intended only for US residents. Oncuria® is a registered trademark
of Nonagen Bioscience Corporation.

©2022 Nonagen Bioscience Corporation. All rights reserved.

 info@nonagen.com